LATEST NEWS AND ARTICLES

From events, scientific articles to PR, you will find here all our latest news.

Why 3D human models will increasingly replace mice in drug testing & How do we make human 3D models not only more relevant — but also reproducible enough for decisions ?
Meet us at the CHU Healthtech Connexion Day on December 8–9 in Bordeaux and discover our 3D bioprinter in action through live demos.
On October 21, our founder Fabien Guillemot will take part in the European Commission’s Joint Research Centre workshop in Brussels: 🧬 “3D Bioprinting: Towards Standards in Biomedicine”
We were delighted to take part in this year’s International Conference on Biofabrication, where we showcased our Next-Generation Bioprinting (NGB) platform through live demos!
Poietis Biosystems' team will be present at TERMIS EU 2025 in Freiburg, Germany from 19 to 23 May. Book your live demonstration of the NGB bioprinter.
7th TERMIS World Congress in Seattle, USA, to discuss the latest advancements in tissue engineering and regenerative medicine !
Poietis and HVD Life Sciences are pleased to announce the signature of their collaboration for the distribution of Poietis’ Next-Generation Bioprinting (NGB) platform designed for translational research in Austria and Germany.
Poietis's NGB platform, offers unparalleled precision in 3D bioprinting, addressing key challenges in organ-on-chip (OoC) development.
We are proud to be partner in the 4-Deep Brain Reconstruction (4-DBR) initiative, a Horizon European Innovation Council (EIC) Pathfinder Open project aimed at revolutionizing the treatment of neurodegenerative disorders.

Do you want to know more about NGB platform?